Latest News and Press Releases
Want to stay updated on the latest news?
-
Total First Nine Months of Fiscal 2020 Revenues of $8.4 million; $1.5 million Net Income; Adjusted EBITDA ($1.7 million) Atlanta, GA, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Streamline Health...
-
Shenzhen, China, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China,...
-
Conference call to be held today at 4:30 p.m. Eastern time NEW YORK, Nov. 17, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly...
-
Company Sales are Up 38.9% from Q2-2020 and Returns To Profitability Miami, Florida, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Blue Star Foods Corp. (OTC:BSFC), (“Blue Star”), a sustainable seafood...
-
Anaheim, CA, Nov. 16, 2020 (GLOBE NEWSWIRE) -- LiveWire Ergogenics Inc. (OTC: LVVV), a company focused on acquiring and managing special purpose real estate properties conducive to producing...
-
Announces Promotion of Lourdes Felix to CEO; Brady Granier to Serve as President ANAHEIM, CA, Nov. 16, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ BioCorRx Inc. (OTCQB: BICX) (the “Company”), a...
-
– Continued progress of COVID-19 development programs with additional preclinical studies of coronavirus protease inhibitors (3CL) underway and lead preclinical molecule selection expected by year end...
-
Highlights for the quarter ended September 30, 2020: ○Net revenues of $10.9 million○Gross profit of $5.7 million, 52% gross profit margin○New customer orders of $10.8 million○New customer software...
-
RUTHERFORD, N.J., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, announced...
-
Charlotte, NC, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Ballantyne Strong, Inc. (NYSE American: BTN) (the “Company”) today announced financial results for the third quarter and nine months ended September...